ATALIE BRADSHAW: Open Payments
NPI 1962148072 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 54 payments from 24 companies in 2025. Trend: 2023 $913 · 2024 $806 · 2025 $1,417
Food & beverage: $1,140Education: $277
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $238 |
| Janssen Biotech, Inc. | 5 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| PFIZER INC. | 4 | $87 |
| Genentech USA, Inc. | 3 | $84 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| EMD Serono, Inc. | 2 | $60 |
| Incyte Corporation | 3 | $58 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $53 |
| Agios Pharmaceuticals, Inc. | 2 | $50 |
Products named: ERLEADA, Itovebi, Xtandi, KEYTRUDA, ENJAYMO, SCEMBLIX, PYRUKYND, NERLYNX.
Industry payments across UT — which companies pay providers there.
